BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38895204)

  • 1. FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS-FTD-associated
    Maitra S; Baek M; Choe YJ; Kim NC
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 and PINK1 mediate CHCHD10
    Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
    Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
    Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
    Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
    Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
    Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHCHD10
    Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
    Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
    Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
    Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
    Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
    FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence.
    Ayoubi R; Alshafie W; Southern K; McPherson PS; Laflamme C;
    F1000Res; 2023; 12():403. PubMed ID: 37767023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
    Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
    Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
    Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
    Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.
    Zhou Q; Chen Y; Wei Q; Cao B; Wu Y; Zhao B; Ou R; Yang J; Chen X; Hadano S; Shang HF
    Mol Neurobiol; 2017 Jul; 54(5):3189-3194. PubMed ID: 27056076
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.